An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...